Phage-derived 12/1 peptide exhibits antitumor activity by targeting MDM2 and MDMX , an thus disrupt the MDM2-p53 and MDMX-p53 interaction, with IC 50 of 0.15 and 1.25 μM.
Products | Products > Peptides | Products > Disease Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MDM-2/p53
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.